2 Results Found

Advanced Search

Select all

Results per page

Select all

Communication

16 Citations

6,699 Views

16 Pages

A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells

Anna M. Serwotka-Suszczak,
Alicja M. Sochaj-Gregorczyk,
Jerzy Pieczykolan,
Daniel Krowarsch,
Filip Jelen and
Jacek Otlewski

Int. J. Mol. Sci.2017, 18(2), 401;https://doi.org/10.3390/ijms18020401

-

14 February 2017

Antibody-drug conjugates (ADCs) have recently emerged as efficient and selective cancer treatment therapeutics. Currently, alternative forms of drug carriers that can replace monoclonal antibodies are under intensive investigation. Here, a cytotoxic...

Full Article

Correction

2,989 Views

1 Page

Correction: Serwotka-Suszczak, A. M. et al. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells. Int. J. Mol. Sci. 2017, 18, 401

Anna M. Serwotka-Suszczak,
Alicja M. Sochaj-Gregorczyk,
Jerzy Pieczykolan,
Daniel Krowarsch,
Filip Jelen and
Jacek Otlewski

Int. J. Mol. Sci.2018, 19(11), 3676;https://doi.org/10.3390/ijms19113676

-

20 November 2018

It has been brought to our attention that the affiliation of Dr. Jerzy Pieczykolan at the time when he was responsible for the work described in the paper [...]

Full Article